These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16010421)
1. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Clement JH; Raida M; Sänger J; Bicknell R; Liu J; Naumann A; Geyer A; Waldau A; Hortschansky P; Schmidt A; Höffken K; Wölft S; Harris AL Int J Oncol; 2005 Aug; 27(2):401-7. PubMed ID: 16010421 [TBL] [Abstract][Full Text] [Related]
2. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Langenfeld EM; Calvano SE; Abou-Nukta F; Lowry SF; Amenta P; Langenfeld J Carcinogenesis; 2003 Sep; 24(9):1445-54. PubMed ID: 12819188 [TBL] [Abstract][Full Text] [Related]
3. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Schwalbe M; Sänger J; Eggers R; Naumann A; Schmidt A; Höffken K; Clement JH Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780 [TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463 [TBL] [Abstract][Full Text] [Related]
8. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715 [TBL] [Abstract][Full Text] [Related]
10. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [TBL] [Abstract][Full Text] [Related]
11. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells. Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185 [TBL] [Abstract][Full Text] [Related]
12. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348 [TBL] [Abstract][Full Text] [Related]
13. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta]. Li Y; Chen N; Yu HJ; Dong XP; Huang QH Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885 [TBL] [Abstract][Full Text] [Related]
14. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Zhang L; Kharbanda S; Chen D; Bullocks J; Miller DL; Ding IY; Hanfelt J; McLeskey SW; Kern FG Oncogene; 1997 Oct; 15(17):2093-108. PubMed ID: 9366526 [TBL] [Abstract][Full Text] [Related]
15. [Screening of a sub-clone of human breast cancer cells with high metastasis potential]. Ye LH; Wu LY; Guo W; Ma HT; Zhang XD Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541 [TBL] [Abstract][Full Text] [Related]
16. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. Ye L; Lewis-Russell JM; Kynaston H; Jiang WG J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Alarmo EL; Kuukasjärvi T; Karhu R; Kallioniemi A Breast Cancer Res Treat; 2007 Jun; 103(2):239-46. PubMed ID: 17004110 [TBL] [Abstract][Full Text] [Related]
18. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Raida M; Clement JH; Ameri K; Han C; Leek RD; Harris AL Int J Oncol; 2005 Jun; 26(6):1465-70. PubMed ID: 15870857 [TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197 [TBL] [Abstract][Full Text] [Related]
20. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Lai TH; Fong YC; Fu WM; Yang RS; Tang CH Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]